By binding to IRF1 to abolish its transcriptional activity, CTD-3252C9.4 inhibits the transcription of IFI6, which then leads to the activation of apoptosis signaling pathway in pancreatic cancer cells. Here, IRF1 is linked to familial pancreatic carcinoma.